- Ongoing, recruitingTherapeutic exploratory (Phase II)
A Phase IIb Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety and Tolerability of AZD5004 in Participants Living with Obesity or Overweight with Comorbidity
This study is testing a new medicine, AZD5004, for people who are overweight or have obesity and other health issues. It aims to see if the medicine helps with weight loss and if it's safe and well-tolerated over 26 weeks.
For: Participants living with Obesity or Overweight with at least 1 comorbidityGermany - Ongoing, recruitingTherapeutic exploratory (Phase II)
A Phase Ilb, Randomized, Double-blind, Placebo controlled and Open-label Active Comparator Study to Evaluate the Efficacy, Safety, and Tolerability of AZD5004 in Adults with Type 2 Diabetes Mellitus
This study is looking at a new medicine called AZD5004 for adults with Type 2 Diabetes. Researchers want to see how well it lowers blood sugar (HbA1c) and if it's safe, compared to a widely used medicine (Rybelsus) or a dummy pill.
For: Type 2 Diabetes MellitusHungary · Germany · Poland